Acomplia has created a rage since its inception. It active ingredient Rimonabant wasdiscovered and developed by a French pharmaceutical company , Sanofi-Aventis. Acomplia is an oral prescription diet drug to tackle obesity.
It works on the principle of obstructing the CB-1 receptors. These receptors are responsible for the regulation of food and nicotine intake. By blocking these receptors, you tend to eat less than your normal appetite, thus causing weight loss. It's effectual also in curbing the unhealthy smoking-habit according to the clinical studies.
The 25-member EU commission finally agreed to make Acomplia saleable in the UK and the rest of Europe in June, 2006. It is soon to be launched in the US, which is anticipated later in 2006.
Besides weight loss, Acomplia also helps to improve cardiovascular/metabolic risk factors related to obesity. In spite of other alternatives that are available in the market, Acomplia still predominates among weight loss drugs due to its affordable price range and optimistic results.
Usage of Acomplia encompasses a few side effects too. A reliable evaluation of side effects can be seen in a part of the approval process report by EMEA (European Medicines Agency). Some of the common side effects of Acomplia drug can be enumerated as:
* Stomach upset
* Dizziness
* Nausea
* Vomiting
* Anxiety
These side effects are temporary and subside once an adjustment to the Acomplia medication has been made. Seek immediate medical assistance in case you experience these side effects for a prolonged time. Prior consultation with your doctor is recommended before embarking upon Acomplia medication.
|
